Literature DB >> 17601375

A novel anti-human syndecan-1 (CD138) monoclonal antibody 4B3: characterization and application.

Wan Ping Sun1, Feng Ming Wang, Fang Xie, Guo Qing Wang, Jin Sun, Ge Hua Yu, Yu Hua Qiu, Xue Guang Zhang.   

Abstract

Syndecan-1 (CD138), a member of integral membrane heparin sulfate proteoglycans, is an essential matrix receptor for maintaining the normal morphological phenotypes. In this study, we generated a specific mouse anti-human syndecan-1 monoclonal antibody (mAb) 4B3 and identified it by competition assay with the available syndecan-1 mAb (BB4). Stained by 4B3, the expression of syndecan-1 was detected on tumor cell lines, such as 8226, U266, XG-1, XG-2, Daudi and Jurkat. The expression was also found on neuron stem cells. It was established that 4B3 mAb could inhibit XG-1 and XG-2 proliferation. The data not only determined that 4B3 mAb was a functional anti-human syndecan-1 mAb, but also indicated that syndecan-1 might be a valuable surface antigen and play an important role in regulation of tumor pathology and differentiation of neural stem cells. This novel antibody 4B3 may be value of study of tumor proliferation/survival mechanism and contributes to diagnosis and treatment of diverse diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17601375

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  7 in total

1.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

2.  Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells.

Authors:  Hua Jiang; Wenhao Zhang; Peipei Shang; Hui Zhang; Weijun Fu; Fei Ye; Tianmei Zeng; Hejing Huang; Xueguang Zhang; Wanping Sun; Daniel Man-Yuen Sze; Qing Yi; Jian Hou
Journal:  Mol Oncol       Date:  2013-12-12       Impact factor: 6.603

3.  Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.

Authors:  Jooeun Bae; Yu-Tzu Tai; Kenneth C Anderson; Nikhil C Munshi
Journal:  Br J Haematol       Date:  2011-09-09       Impact factor: 6.998

Review 4.  Targeting syndecan-1: new opportunities in cancer therapy.

Authors:  Zecheng Yang; Shuaitong Chen; Haoqiang Ying; Wantong Yao
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-18       Impact factor: 5.282

5.  New tags for recombinant protein detection and O-glycosylation reporters.

Authors:  Gianluca Petris; Marco Bestagno; Francesca Arnoldi; Oscar R Burrone
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

6.  Fine Mutational Analysis of 2B8 and 3H7 Tag Epitopes with Corresponding Specific Monoclonal Antibodies.

Authors:  Tae-Lim Kim; Man-Ho Cho; Kanidta Sangsawang; Seong Hee Bhoo
Journal:  Mol Cells       Date:  2016-05-03       Impact factor: 5.034

7.  A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.

Authors:  Lijun Shen; Ying Zhu; Lianhua Han; Yuyu Wang; Tianming Yan; Yong Kong; Shitao Zou; Yuhua Qiu; Yan Xu
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.